1. Becker JC, Beer AJ, DeTemple VK, Eigentler T, Flaig M, Gambichler T, Grabbe S, Höller U, Klumpp B, Lang S, Pföhler C, Posch C, Prasad V, Schlattmann P, Schneider-Burrus S, Ter-Nedden J, Terheyden P, Thoms K, Vordermark D, Ugurel S. S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022. J Dtsch Dermatol Ges 2023; 21: 305-17.
  2. Deininger K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, Muehling B, Beer M, Glatting G, Beer AJ, Thaiss W. Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC. Nuklearmedizin 2023.
  3. Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry. Eur J Nucl Med Mol Imaging 2023; 50: 2595-604.
  4. Gaidzik VI, Beer AJ, Thaiss W. Precision medicine: imaging in the context of the molecular tumor board. Onkologie 2023: 6.
  5. Gierse M, Nagel L, Keim M, Lucas S, Speidel T, Lobmeyer T, Winter G, Josten F, Karaali S, Fellermann M, Scheuer J, Müller C, van Heijster F, Skinner J, Löffler J, Parker A, Handwerker J, Marshall A, Salhov A, El-Kassem B, Vassiliou C, Blanchard JW, Picazo-Frutos R, Eills J, Barth H, Jelezko F, Rasche V, Schilling F, Schwartz I, Knecht S. Parahydrogen-Polarized Fumarate for Preclinical in Vivo Metabolic Magnetic Resonance Imaging. J Am Chem Soc 2023
  6. Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept. Ejnmmi Physics 2023; 10: 12.
  7. Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model. Zeitschrift für Medizinische Physik 2022.
  8. Hardiansyah D, Riana A, Eiber M, Beer AJ, Glatting G. Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling. Z Med Phys 2023.
  9. Harms M, Fabech Hansson R, Gilg A, Almeida-Hernández Y, Löffler J, Rodríguez-Alfonso A, Habib MMW, Albers D, Ahmed NS, Abadi AH, Winter G, Rasche V, Beer AJ, Weidinger G, Preising N, Ständker L, Wiese S, Sanchez-Garcia E, Zelikin AN, Münch J. Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability. J Med Chem 2023
  10. Hilbrig C, Löffler J, Fischer G, Scheidhauer E, Solbach C, Huber-Lang M, Beer AJ, Rasche V, Winter G. Evaluation of the EPR Effect in the CAM-Model by Molecular Imaging with MRI and PET Using 89Zr-Labeled HSA. Cancers 2023; 15: 1126
  11. Illert AL, Stenzinger A, Bitzer M, Horak P, Gaidzik VI, Möller Y, Beha J, Öner Ö, Schmitt F, Laßmann S, Ossowski S, Schaaf CP, Hallek M, Brümmendorf TH, Albers P, Fehm T, Brossart P, Glimm H, Schadendorf D, Bleckmann A, Brandts CH, Esposito I, Mack E, Peters C, Bokemeyer C, Fröhling S, Kindler T, Algül H, Heinemann V, Döhner H, Bargou R, Ellenrieder V, Hillemanns P, Lordick F, Hochhaus A, Beckmann MW, Pukrop T, Trepel M, Sundmacher L, Wesselmann S, Nettekoven G, Kohlhuber F, Heinze O, Budczies J, Werner M, Nikolaou K, Beer AJ, Tabatabai G, Weichert W, Keilholz U, Boerries M, Kohlbacher O, Duyster J, Thimme R, Seufferlein T, Schirmacher P, Malek NP. The German Network for Personalized Medicine to enhance patient care and translational research. Nat Med 2023; 29: 1298-301.
  12. Ivashchenko OV, O'Doherty J, Hardiansyah D, Cremonesi M, Tran-Gia J, Hippeläinen E, Stokke C, Grassi E, Sandström M, Glatting G. Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls. Physica Medica 2023: 103192
  13. Kloth C, Beck A, Sollmann N, Beer M, Horger M, Thaiss WM. Imaging of Pathologies of the Temporal Bone and Middle Ear: Inflammatory Diseases, Their Mimics and Potential Complications-Pictorial Review. Tomography 2023; 9: 2190-210.
  14. Lassmann M, Glatting G. Bedeutung der Dosimetrie bei der Therapie aus Sicht der Medizinischen Physik. Angewandte Nuklearmed 2023; 46:69-73.
  15. Lazovic J, Goering E, Wild AM, Schützendübe P, Shiva A, Löffler J, Winter G, Sitti M. Nanodiamond-Enhanced Magnetic Resonance Imaging. Adv Mater 2023: 14.
  16. Lingl JP, Böhm F, Schuler PJ, Hoffmann TK, Deininger K, Beer M, Beer AJ, Thaiss W. [Value of PET imaging in head and neck cancer]. Radiologie (Heidelb) 2023; 63: 925-36.
  17. Lingl JP, Böhm F, Schuler PJ, Hoffmann TK, Deininger K, Beer M, Beer AJ, Thaiss W. [Value of PET imaging in head and neck cancer]. HNO 2023; 71: 681-92.
  18. Lisson CS, Manoj S, Wolf D, Lisson CG, Schmidt SA, Beer M, Thaiss W, Bolenz C, Zengerling F, Goetz M. Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer. Cancers (Basel). 2023;15(23):5630. doi: 10.3390/cancers15235630. PMID: 38067334.
  19. More S, Naiker T, Jacobs N, Oompie F, Prasad V. Short-Interval, Low-Dose <SUP>177</SUP>Lu Lu-Prostate-Specific Membrane Antigen in the Treatment of Refractory Glioblastoma. Clin Nucl Med 2023; 48: E217-E8.
  20. Müller D, Herrmann H, Schultz MK, Solbach C, Ettrich T, Prasad V. Pb-203-VMT-alpha-NET Scintigraphy of a Patient With Neuroendocrine Tumor. Clin Nucl Med 2023; 48: 54-5.
  21. Nasir Z, Probst L, Schneider F, Clausen S, Burgy D, Glatting G, Nwankwo O. Organ absorbed doses in the IORT treatment of breast cancer with the INTRABEAM device: a Monte-Carlo study. Biomedical Physics & Engineering Express 2023; 9: 11
  22. Peters L, Jiang WJ, Eberhardt N, Hagemann JB, Grüner B, Tappe D. 18FDG-PET/CT-Scans and Biomarker Levels Predicting Clinical Outcome in Patients with Alveolar Echinococcosis-A Single-Center Cohort Study with 179 Patients. Pathogens 2023; 12: 15.
  23. Pouget JP, Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K, Holm S, Strigari L, van Leeuwen FWB, Lassmann M. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging 2023; 50(2): 242-246
  24. Rahbar K, Essler M, Pabst KM, Eiber M, la Fouge C, Prasad V, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Fendler WP, Kurtinecz M, Schmall A, Verholen F, Sartor O. Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study. J Nucl Med 2023; 64: 574-8.
  25. Riehl L, Mulaw M, Kneer K, Beer M, Beer A, Bart TF, Benes V, Schulte J, Fischer M, Debatin KM, Beltinger C. Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma. Cancer Reports 2023; 6: 12.
  26. Schulze R, Solbach C, Patt M, Breitkreutz F. Requirements for the qualified person in radiopharmacy. Nuklearmedizin 2023; 62: 75-8.
  27. Strobel J, Müller HP, Ludolph AC, Beer AJ, Sollmann N, Kassubek J. New Perspectives in Radiological and Radiopharmaceutical Hybrid Imaging in Progressive Supranuclear Palsy: A Systematic Review. Cells 2023; 12: 35.
  28. Thaiss W, Zengerling F, Friedrich J, Hechler V, Grunert M, Bolenz C, Wiegel T, Beer AJ, Prasad V. Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre. Cancers 2023; 15(12): 3216.
  29. Vogele D, Schmidt SA, Gnutzmann D, Thaiss WM, Ettrich TJ, Kornmann M, Beer M, Juchems MS. Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging. Diagnostics (Basel). 2023;13(17):2741. doi: 10.3390/diagnostics13172741. PMID: 37685279
  30. Wanek T, Mairinger S, Raabe M, Alam MNA, Filip T, Stanek J, Winter G, Xu L, Laube C, Weil T, Rasche V, Kuntner C. Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds. Nucl Med Biol 2023; 116-117: 108310
  31. Weikert T, Jaeger PF, Yang S, Baumgartner M, Breit HC, Winkel DJ, Sommer G, Stieltjes B, Thaiss W, Bremerich J, Maier-Hein KH, Sauter AW. Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation. Eur Radiol 2023; 33: 4270-9.
  32. Westphal K, Eiber M, Henninger M, Scheidhauer K, Beer AJ, Thaiss W, Rischpler C. Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study. Medicine 2023; 102: 9.
  33. Winter G, Hamp-Goldstein C, Fischer G, Kletting P, Glatting G, Solbach C, Herrmann H, Sala E, Feuring M, Döhner H, Beer AJ, Bunjes D, Prasad V. Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation. Cancers 2023; 15: 3660.
  34. Zaid NRR, Kletting P, Beer AJ, Rozgaja Stallons TA, Torgue JJ, Glatting G. Mathematical modeling of in vivo alpha particle generators and chelator stability. Cancer Biother Radiopharm 2023; 38(8): 528-535